Cite

HARVARD Citation

    Li, X. et al. (n.d.). Anti-HER3 Monoclonal Antibody Inhibits Acquired Trastuzumab-Resistant Gynecologic Cancers. Technology in cancer research & treatment. pp. 573-582. [Online]. 
  
Back to record